Collegium Pharmaceutical (COLL) EPS (Diluted) Growth (1y) (2015 - 2026)
Collegium Pharmaceutical (COLL) EPS (Diluted) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Collegium Pharmaceutical | 891.70 Mn | 742.38 Mn | 110.29 Mn | -251.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -251.20% |
| Mar 31, 2026 | 391.59% |
| Dec 31, 2025 | 37.78% |
| Sep 30, 2025 | 243.71% |
| Jun 30, 2025 | -36.84% |
| Mar 31, 2025 | -88.99% |
| Dec 31, 2024 | -59.43% |
| Sep 30, 2024 | -52.62% |
| Jun 30, 2024 | 59.94% |
| Mar 31, 2024 | 231.71% |
| Dec 31, 2023 | 459.17% |
| Sep 30, 2023 | 3,611.19% |
| Jun 30, 2023 | 298.83% |
| Mar 31, 2023 | -30.83% |
| Dec 31, 2022 | 65.11% |
| Sep 30, 2022 | -94.04% |
| Jun 30, 2022 | -108.52% |
| Mar 31, 2022 | -194.93% |
| Dec 31, 2021 | -408.12% |
| Sep 30, 2021 | -31.05% |